Board Meeting29 Jul 2026, 08:00 pm
Chemfab Alkalis Board Approves Q1 FY27 Un-Audited Results
AI Summary
Chemfab Alkalis Ltd announced that its Board of Directors, in a meeting held on July 29, 2026, approved the Un-Audited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The Board also approved the appointment of M/s. M S K A & Associates LLP as the Statutory Auditors for a five-year term, subject to shareholder approval at the upcoming AGM. This appointment follows the expiry of the tenure of the current auditor, Deloitte Haskins & Sells LLP.
Key Highlights
- Board approved Un-Audited Standalone & Consolidated Financial Results for Q1 FY27.
- Appointment of M S K A & Associates LLP as new Statutory Auditors approved.
- New auditors appointed for a five-year term.
- Shareholder approval required for the auditor appointment at the AGM.
- Current auditor's tenure with Deloitte Haskins & Sells LLP is expiring.
Price Impact
More from CHEMFABALKA
More in Board Meeting